4,0
6. Juni 2015
Mitarbeiter (anonym)
Aktueller Mitarbeiter, mehr als 3 Jahre
Dorado, PR
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Tremendous industry knowledge in the Life Sciences and Regulated industries. Good opportunities in the Pharmaceutical, Medical Device, and FDA governed areas. Expanding with new division and penetrating new global regions.
Kontras
No cost of living adjustment, no evaluations provided in 3 1/2 years, no promotion or salary increase. No using historical presence and client base to promote all divisions equally.